Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Alan Ezekowitz
26 Jun 2026
Director
Sell
18,000
$3.65
$65.61K
Robert J Gould
2 Feb 2026
Director
Sell
15,000
$10.72
$160.86K
Robert J Gould
2 Jan 2026
Director
Sell
15,000
$11.87
$178.09K
Curtis Gale Oltmans
15 Dec 2025
Chief Legal Officer
Sell
3,452
$12.92
$44.60K
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
91,722
$14.98
$1.37M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
2,706,397
$14.28
$38.65M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
1,377,020
$13.33
$18.36M
Robert J Gould
19 Nov 2025
Director
Sell
15,000
$11.03
$165.50K
Greg Tourangeau
8 May 2025
Principal Accounting Officer
Sell
498
$5.06
$2.52K
Greg Tourangeau
7 May 2024
Principal Accounting Officer
Sell
236
$7.76
$1.83K
Greg Tourangeau
8 Mar 2024
Vice President, Finance
Sell
4,884
$11.72
$57.22K
Greg Tourangeau
10 May 2023
Principal Accounting Officer
Sell
210
$3.31
$695.10
Robert J Gould
13 Jan 2023
Interim President & CEO
Sell
6,766
$15.00
$101.49K
Robert J Gould
16 Mar 2021
See Remarks
Sell
789
$12.43
$9.81K
Robert J Gould
15 Mar 2021
See Remarks
Sell
9,211
$12.13
$111.77K
Robert J Gould
16 Feb 2021
See Remarks
Sell
1,673
$14.56
$24.37K
Robert J Gould
16 Feb 2021
See Remarks
Sell
6,542
$14.19
$92.83K
Peter G. Thomson
21 Jan 2021
VP Finance & Accounting
Sell
6,607
$14.00
$92.50K
Robert J Gould
20 Jan 2021
See Remarks
Sell
10,000
$12.08
$120.83K
Robert J Gould
8 Jul 2020
See Remarks
Sell
2,500
$20.00
$50.00K
Diego Cadavid
1 Jul 2020
SVP Clinical Development
Sell
1,071
$18.30
$19.60K
Robert J Gould
25 Jun 2020
See Remarks
Sell
2,500
$20.80
$51.99K
Robert J Gould
9 Jun 2020
See Remarks
Sell
156
$20.00
$3.12K
Robert J Gould
5 Jun 2020
See Remarks
Sell
3,433
$20.17
$69.25K
Robert J Gould
4 Jun 2020
See Remarks
Sell
1,300
$20.04
$26.06K
Robert J Gould
3 Jun 2020
See Remarks
Sell
1,500
$20.13
$30.19K
Robert J Gould
2 Jun 2020
See Remarks
Sell
2,797
$20.00
$55.94K
Robert J Gould
1 Jun 2020
See Remarks
Sell
5
$20.00
$100.00
Robert J Gould
29 May 2020
See Remarks
Sell
1,390
$20.08
$27.91K
Robert J Gould
28 May 2020
See Remarks
Sell
1,919
$20.01
$38.39K
Robert J Gould
26 May 2020
See Remarks
Sell
2,500
$20.00
$50.00K
Peter G. Thomson
11 May 2020
VP Finance & Accounting
Sell
7,500
$16.00
$120.00K
Diego Cadavid
2 Mar 2020
SVP Clinical Development
Sell
315
$18.13
$5.71K
Diego Cadavid
2 Mar 2020
SVP Clinical Development
Sell
1,828
$17.26
$31.55K
Peter G. Thomson
24 Feb 2020
VP Finance & Accounting
Sell
250
$18.61
$4.65K
Peter G. Thomson
24 Feb 2020
VP Finance & Accounting
Sell
2,102
$17.43
$36.64K
Peter G. Thomson
24 Feb 2020
VP Finance & Accounting
Sell
2,648
$16.18
$42.86K
Robert J Gould
19 Feb 2020
See Remarks
Sell
2,500
$20.00
$50.00K
Diego Cadavid
3 Feb 2020
SVP Clinical Development
Sell
2,143
$17.33
$37.14K
Peter G. Thomson
23 Jan 2020
VP Finance & Accounting
Sell
262
$18.05
$4.73K
Peter G. Thomson
23 Jan 2020
VP Finance & Accounting
Sell
4,738
$17.17
$81.37K

What was left out

Form 4 filings counted 183
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 28
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 32,104,196
Sales filed before the plan box existed 29
History held since 18 Jul 2019